Curevac

This was an early-stage study to test the safety of a new mRNA vaccine, called CVGBM, for patients with a specific, aggressive type of brain tumor called glioblastoma. The study involved 37 adults who had their tumor surgically removed and completed standard radiation therapy. Th…